Back to Report Store Home

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

  • Published: Jun-2017
  • Report Code: GBIHC443MR
  • Report Format: pdf

Description

List of Tables

Table 1: Pain Therapeutics Market, Global, Approved Indications for Celebrex, 2017 23

Table 2: Pain Therapeutics Market, Global, Approved Indications for Nucynta, 2017 24

Table 3: Pain Therapeutics Market, Global, Approved Indications for Lyrica, 2017 26

Table 4: Pain Therapeutics Market, Global, Approved Indications for Exparel, 2017 27

Table 5: Pain Therapeutics Market, Global, Approved Indications for Voltaren, 2017 28

Table 6: Pain Therapeutics Market, Global, Approved Indications for Pennsaid, 2017 29

Table 7: Pain Therapeutics Market, Global, Approved Indications for Depakine, 2017 30

Table 8: Pain Therapeutics Market, Global, Approved Indications for Embeda ER, 2017 31

Table 9: Pain Therapeutics Market, Global, Approved Indications for Cymbalta, 2017 33

Table 10: Pain Therapeutics Market, Global, Usage of Generics Across Key Indications, 2016 68

Table 11: Pain Therapeutics Market, Global, Forecast Revenues by Company, 2016–2023 82

Table 12: Pain Therapeutics Market, Global, Pipeline Products, Discovery, 2017 110

Table 13: Pain Therapeutics Market, Global, Pipeline Products, Preclinical, 2017 115

Table 14: Pain Therapeutics Market, Global, Pipeline Products, IND/CTA-filed, 2017 131

Table 15: Pain Therapeutics Market, Global, Pipeline Products, Phase I, 2017 131

Table 16: Pain Therapeutics Market, Global, Pipeline Products, Phase II, 2017 135

Table 17: Pain Therapeutics Market 138

Table 18: Pain Therapeutics Market, Global, Pipeline Products, Pre-registration, 2017 141

Table 19: Pain Therapeutics Market, Global, Pipeline Products, Unknown, 2017 141

Table 20: Pain therapeutics Market, Epidemiology Patterns for Migraine, 2016–2023 142

Table 21: Pain therapeutics Market, Epidemiology Patterns for Post-Herpetic Neuralgia, 2016–2023 143

Table 22: Pain therapeutics Market, Epidemiology Patterns for Trigeminal Neuralgia, 2016–2023 143

Table 23: Abbreviations 144

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards